Note 17 - Shareholders' Equity |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Stockholders' Equity Note [Abstract] | |
| Shareholders' Equity | NOTE 17: SHAREHOLDERS’ EQUITY The Company has 560 million shares of authorized stock, consisting of: (i) 500 million shares of common stock, par value $0.01 per share and (ii) 60 million shares of preferred stock, no par value, issuable in one or more series. Common Stock As of June 30, 2026 and December 31, 2025, there were 97.9 million and 97.4 million shares of common stock outstanding, respectively. Preferred Stock Series B Preferred stock issued and outstanding included 1.0 million shares of 6.0% Series B Preferred Stock at June 30, 2026 and 1.0 million shares of 4.0% Series B Preferred Stock at December 31, 2025 . Treasury Stock Treasury stock consisted of approximately 3.3 million and 3.0 million shares as of June 30, 2026 and December 31, 2025, respectively. Supplemental Resale Registration On July 1, 2026 the Company filed a Registration Statement on Form S-3, which was declared effective on July 8, 2026, to register the resale of up to an additional 4,426,268 shares of the Company's common stock by GO EK Ventures IV, LLC and funds advised by Kennedy Lewis Management LP to perform its obligations under existing registration rights agreements. Of the shares covered by the registration statement, 3,451,113 shares are currently issued and outstanding and 975,155 shares are issuable upon the conversion of a portion of the outstanding shares of 6% Series B Preferred stock. In conjunction with the filing of the registration statement, the Company filed a prospectus supplement associated with a previously existing effective registration statement to, among other updates, remove from the corresponding prospectus 5,031,489 shares of common stock that will not be sold pursuant to such previously existing registration statement. |